Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.200
0.00 (0.00%)
Feb 23, 2026, 3:49 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 86.26 million as of February 23, 2026. Its market cap has increased by 6.32% in one year.
Market Cap
86.26M
Enterprise Value
138.93M
Revenue
45.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.20
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 86.26M, a decrease of -87.09%. That is a compound annual growth rate of -33.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 86.26M | -2.44% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | 668.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 1.55B |
| Nykode Therapeutics AS | 1.23B |
| ArcticZymes Technologies ASA | 1.14B |
| Lytix Biopharma AS | 687.81M |
| Zelluna ASA | 417.74M |
| Circio Holding ASA | 318.65M |
| SoftOx Solutions AS | 135.90M |
| EXACT Therapeutics AS | 107.55M |